Cyberdyne Overview
- Year Founded
-
2004
- Status
-
Public
- Employees
-
260
- Stock Symbol
-
7779
- Investments
-
31
- Share Price
-
$1.18
- (As of Thursday Closing)
Cyberdyne General Information
Description
Cyberdyne Inc provides solutions based on its core technology, HCPS Cybernics with Physical AI - a human-centered approach that fuses bio/medical sciences with AI, robotics, and information technologies, and encompasses AI operating in the physical world, including AI-powered robots. These solutions are driven by two complementary domains: Cybernics Medical and Healthcare Innovation, which integrates and harmonizes the medical and non-medical sectors to comprehensively address healthcare and wellness, and Cybernics Life Innovation, which supports the mobility and work of people and goods. Its products include Medical HAL - Lower Limb Type, Medical HAL - Single Joint Type, Well-Being HAL - Lower Limb Type, Well-being HAL - Single Joint Type, HAL Lumbar Type for Well-being, among others.
Contact Information
Website
www.cyberdyne.jpCorporate Office
- 2-2-1, Gakuen-Minami
- Ibaraki Prefecture
- Tsukuba, Ibaraki 305-0818
- Japan
Corporate Office
- 2-2-1, Gakuen-Minami
- Ibaraki Prefecture
- Tsukuba, Ibaraki 305-0818
- Japan
Cyberdyne Stock Performance
As of 12-Nov-2026, Cyberdyne’s stock price is $1.18. Its current market cap is $250M with 211M shares.
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $1.18 | $1.21 | $1.05 - $2.72 | $250M | 211M | 1.07M |
Cyberdyne Financials Summary
As of 30-Jun-2026, Cyberdyne has a trailing 12-month revenue of $25.1M.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2026 31-Mar-2026 | FY 2025 31-Mar-2025 | FY 2024 31-Mar-2024 |
|---|---|---|---|---|
| EV | 217,547 | 256,093 | 144,230 | 189,124 |
| Revenue | 25,082 | 25,517 | 28,748 | 30,134 |
| EBITDA | 1,969 | 1,897 | (3,430) | (3,633) |
| Net Income | 1,787 | 1,015 | (3,784) | (10,215) |
| Total Assets | 307,147 | 307,029 | 324,420 | 330,353 |
| Total Debt | 3,335 | 2,921 | 2,900 | 4,176 |
Cyberdyne Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Cyberdyne Comparisons
Industry
Financing
Details
Cyberdyne Competitors (13)
One of Cyberdyne’s 13 competitors is Hocoma, a Corporate Backed or Acquired company based in Volketswil, Switzerland.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Hocoma | Corporate Backed or Acquired | Volketswil, Switzerland | ||||
| Lifeward | Formerly VC-backed | Yokneam Ilit, Israel | ||||
| Joerns Healthcare | Private Equity-Backed | Charlotte, NC | ||||
| Embla Medical | Corporation | Reykjavik, Iceland | ||||
| Bionik Laboratories | Formerly PE-Backed | Toronto, Canada |
Cyberdyne Patents
Cyberdyne Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026230184-A1 | Activity coordination support system and activity coordination support method | Pending | 30-Apr-2025 | ||
| JP-2026180091-A | Pending | 30-Apr-2025 | |||
| JP-2026112319-A | Cell therapy | Pending | 24-Dec-2024 | ||
| JP-2026092613-A | Photoacoustic imaging apparatus and photoacoustic imaging method | Pending | 26-Nov-2024 | ||
| WO-2026115929-A1 | Photoacoustic imaging device and photoacoustic imaging method | Pending | 26-Nov-2024 |
Cyberdyne Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Cyberdyne Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Cyberdyne Investments & Acquisitions (31)
Cyberdyne’s most recent deal was a Later Stage VC with CynosBio for . The deal was made on 22-Jul-2024.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| CynosBio | 22-Jul-2024 | Later Stage VC | Drug Discovery | ||
| LeyLine (Holding Companies) | 29-Mar-2023 | Merger/Acquisition | Holding Companies | ||
| Jiksak Bioengineering | 29-Aug-2022 | Later Stage VC | Drug Discovery | ||
| Xenoma | 10-Aug-2022 | Later Stage VC | Clothing | ||
| Kamui Pharma | 26-Jul-2022 | Early Stage VC | Drug Discovery |
Cyberdyne ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
35.86 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,585
Rank
Percentile
Healthcare
Industry
of 590
Rank
Percentile
Medical Devices
Subindustry
of 209
Rank
Percentile
Cyberdyne Exits (7)
Cyberdyne’s most recent exit was on 05-Apr-2021 from Allm. The exit was categorized as with 19 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Allm | 05-Apr-2021 | Completed |
|
||
| SmartScan (Decision/Risk Analysis) | 22-Nov-2019 | Completed |
|
||
| Miraisens | 15-Jun-2017 | Completed |
|
||
| Kringle Pharma | 05-Dec-2016 | Completed |
|
||
| WHILL | 10-Nov-2016 | Early Stage VC | Completed |
|
Cyberdyne Affiliates
Subsidiaries (8)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| CEJ Capital | Tsukuba, Japan | 2017 | |
| Rise Physical Therapy | Solana Beach, CA | 2014 | |
| Oita Lobo Care Center Co. | Beppu, Japan | 2013 | |
| Shonan Robocare Center Co. | Fujisawa, Japan | 2013 | |
| Suzuka Lobo Care Center Co. | Suzuka, Japan | 2013 |
Cyberdyne FAQs
-
When was Cyberdyne founded?
Cyberdyne was founded in 2004.
-
Where is Cyberdyne headquartered?
Cyberdyne is headquartered in Tsukuba, Japan.
-
What is the size of Cyberdyne?
Cyberdyne has 260 total employees.
-
What industry is Cyberdyne in?
Cyberdyne’s primary industry is Therapeutic Devices.
-
Is Cyberdyne a private or public company?
Cyberdyne is a Public company.
-
What is Cyberdyne’s stock symbol?
The ticker symbol for Cyberdyne is 7779.
-
What is the current stock price of Cyberdyne?
As of 12-Nov-2026 the stock price of Cyberdyne is $1.18.
-
What is the current market cap of Cyberdyne?
The current market capitalization of Cyberdyne is $250M.
-
What is Cyberdyne’s current revenue?
The trailing twelve month revenue for Cyberdyne is $25.1M.
-
Who are Cyberdyne’s competitors?
Hocoma, Lifeward, Joerns Healthcare, Embla Medical, and Bionik Laboratories are some of the 13 competitors of Cyberdyne.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
